196 related articles for article (PubMed ID: 9027616)
1. Clinical detection of lung cancer progression markers.
Tockman MS
J Cell Biochem Suppl; 1996; 25():177-84. PubMed ID: 9027616
[TBL] [Abstract][Full Text] [Related]
2. A case-cohort study of an early biomarker of lung cancer in a screening cohort of Yunnan tin miners in China.
Qiao YL; Tockman MS; Li L; Erozan YS; Yao SX; Barrett MJ; Zhou WH; Giffen CA; Luo XC; Taylor PR
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):893-900. PubMed ID: 9367062
[TBL] [Abstract][Full Text] [Related]
3. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression.
Tockman MS; Mulshine JL; Piantadosi S; Erozan YS; Gupta PK; Ruckdeschel JC; Taylor PR; Zhukov T; Zhou WH; Qiao YL; Yao SX
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2237-46. PubMed ID: 9815620
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers.
Sueoka E; Goto Y; Sueoka N; Kai Y; Kozu T; Fujiki H
Cancer Res; 1999 Apr; 59(7):1404-7. PubMed ID: 10197602
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer: chemoprevention and intermediate effect markers.
Tockman MS
IARC Sci Publ; 2001; 154():257-70. PubMed ID: 11220665
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of splicing factor, heterogeneous nuclear ribonucleoprotein A2/B1, in mouse lung neoplasia.
Peebles KA; Dwyer-Nield LD; Malkinson AM
Mol Carcinog; 2007 Nov; 46(11):887-900. PubMed ID: 17477362
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer.
Zech VF; Dlaska M; Tzankov A; Hilbe W
Cancer Detect Prev; 2006; 30(5):395-402. PubMed ID: 17067748
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1.
Fujimoto N; Sueoka N; Sueoka E; Okabe S; Suganuma M; Harada M; Fujiki H
Int J Oncol; 2002 Jun; 20(6):1233-9. PubMed ID: 12012004
[TBL] [Abstract][Full Text] [Related]
9. [Detection of oncogenic mutations in sputum and its diagnostic value of lung cancer].
Wang L; Wang G; Xia X
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Apr; 21(4):236-9. PubMed ID: 11326973
[TBL] [Abstract][Full Text] [Related]
10. Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction.
Sueoka E; Sueoka N; Iwanaga K; Sato A; Suga K; Hayashi S; Nagasawa K; Nakachi K
Lung Cancer; 2005 Apr; 48(1):77-83. PubMed ID: 15777973
[TBL] [Abstract][Full Text] [Related]
11. Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention.
Wiest JS; Franklin WA; Drabkin H; Gemmill R; Sidransky D; Anderson MW
J Cell Biochem Suppl; 1997; 28-29():64-73. PubMed ID: 9589350
[TBL] [Abstract][Full Text] [Related]
12. Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokers.
Zhou J; Mulshine JL; Ro JY; Avis I; Yu R; Lee JJ; Morice R; Lippman SM; Lee JS
Clin Cancer Res; 1998 Jul; 4(7):1631-40. PubMed ID: 9676837
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of hnRNPA2/B1 in bronchoscopic specimens: a potential early detection marker in lung cancer.
Katsimpoula S; Patrinou-Georgoula M; Makrilia N; Dimakou K; Guialis A; Orfanidou D; Syrigos KN
Anticancer Res; 2009 Apr; 29(4):1373-82. PubMed ID: 19414390
[TBL] [Abstract][Full Text] [Related]
14. Biological markers in lung cancer: A clinician's perspective.
Tufman A; Huber RM
Cancer Biomark; 2010; 6(3-4):123-35. PubMed ID: 20660959
[TBL] [Abstract][Full Text] [Related]
15. Examination of p53 alterations and cytokeratin expression in sputa collected from patients prior to histological diagnosis of squamous cell carcinoma.
Anderson M; Sladon S; Michels R; Davidson L; Conwell K; Lechner J; Franklin W; Saccomanno G; Wiest J
J Cell Biochem Suppl; 1996; 25():185-90. PubMed ID: 9027617
[TBL] [Abstract][Full Text] [Related]
16. hnRNP B1 expression in benign and malignant lung disease.
Snead DR; Perunovic B; Cullen N; Needham M; Dhillon DP; Satoh H; Kamma H
J Pathol; 2003 May; 200(1):88-94. PubMed ID: 12692846
[TBL] [Abstract][Full Text] [Related]
17. [Lung cancer].
Haugen A
Tidsskr Nor Laegeforen; 1998 Jun; 118(15):2362-5. PubMed ID: 9691805
[TBL] [Abstract][Full Text] [Related]
18. Molecular diagnostic markers for lung cancer in sputum and plasma.
Wang YC; Hsu HS; Chen TP; Chen JT
Ann N Y Acad Sci; 2006 Sep; 1075():179-84. PubMed ID: 17108209
[TBL] [Abstract][Full Text] [Related]
19. p53 and lung cancer.
Brambilla E; Brambilla C
Pathol Biol (Paris); 1997 Dec; 45(10):852-63. PubMed ID: 9769949
[TBL] [Abstract][Full Text] [Related]
20. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE
Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
